Many patients are looking forward to trying the new inhaled insulin, Exubera

Many patients are looking forward to trying the new inhaled insulin, Exubera, when it comes out later this summer.

It will be an alternative to short-acting mealtime insulin.

It has a fast onset like Humalog or Novolog...but a longer duration like regular insulin (Humulin R, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote